---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-035508"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:28:30.598594+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics prices $175M offering of common stock and pre-funded warrants at $3.79/share

## Summary
- Gross proceeds ~$175M from 39,576,088 shares at $3.79/share and 6,598,046 pre-funded warrants at $3.789.
- Offering closed Feb 3, 2026; net proceeds to fund clinical development, manufacturing, and general corp purposes.
- Underwriters include Piper Sandler, UBS, Oppenheimer, Truist, and LifeSci Capital.
- Participation from Commodore Capital, TCGX, Spruce Street Capital, Surveyor Capital (Citadel), and others.

## SEC filing metadata
- accession: 0001193125-26-035508
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000119312526035508/0001193125-26-035508-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000119312526035508/catx-20260202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-035508
- JSON: https://secwatch.observer/filing/0001193125-26-035508.json
- Plain text: https://secwatch.observer/filing/0001193125-26-035508.txt

## Key facts
- Material Agreements
  Perspective Therapeutics, Inc. entered into Underwriting Agreement with Piper Sandler & Co. and UBS Securities LLC, as representatives of the underwriters named therein valued at approximately $175 million (effective 2026-02-02).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Piper Sandler & Co. and UBS Securities LLC, as representatives of the underwriters named therein
  - Value: approximately $175 million
  - Effective: 2026-02-02
  source text: On February 2, 2026, Perspective Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Piper Sandler & Co. and UBS Securities LLC, as representatives of the underwriters named therein (the “Underwriters”), in connection with its previously announced underwritten offering (the “Offering”) of 39,576,088 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and, in lieu of Shares to certain investors, pre-funded warrants (the “Pre-Funded Warrants”) to purchase 6,598,046 shares of Common Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000119312526035508/0001193125-26-035508-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.